nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—connective tissue—celiac disease	0.0289	0.0375	CbGeAlD
Bortezomib—PSMA1—connective tissue—celiac disease	0.0277	0.036	CbGeAlD
Bortezomib—PSMA1—epithelium—celiac disease	0.0263	0.0341	CbGeAlD
Bortezomib—PSMD1—smooth muscle tissue—celiac disease	0.0213	0.0276	CbGeAlD
Bortezomib—CTSG—lymphoid tissue—celiac disease	0.0211	0.0274	CbGeAlD
Bortezomib—CYP2C19—urine—celiac disease	0.0203	0.0263	CbGeAlD
Bortezomib—PSMA1—lymphoid tissue—celiac disease	0.0203	0.0263	CbGeAlD
Bortezomib—PSMA1—digestive system—celiac disease	0.02	0.026	CbGeAlD
Bortezomib—CTSG—blood—celiac disease	0.0199	0.0258	CbGeAlD
Bortezomib—PSMD1—pancreas—celiac disease	0.0197	0.0255	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—celiac disease	0.0189	0.0245	CbGeAlD
Bortezomib—PSMD2—pancreas—celiac disease	0.0174	0.0226	CbGeAlD
Bortezomib—PSMB8—pancreas—celiac disease	0.0173	0.0225	CbGeAlD
Bortezomib—CYP1A2—urine—celiac disease	0.0166	0.0215	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—celiac disease	0.0166	0.0215	CbGeAlD
Bortezomib—PSMD1—blood—celiac disease	0.016	0.0208	CbGeAlD
Bortezomib—CYP2C9—urine—celiac disease	0.0157	0.0204	CbGeAlD
Bortezomib—PSMB2—connective tissue—celiac disease	0.0154	0.02	CbGeAlD
Bortezomib—PSMB5—pancreas—celiac disease	0.0153	0.0199	CbGeAlD
Bortezomib—PSMD2—lymphoid tissue—celiac disease	0.0151	0.0196	CbGeAlD
Bortezomib—PSMA1—liver—celiac disease	0.0149	0.0194	CbGeAlD
Bortezomib—PSMD2—digestive system—celiac disease	0.0149	0.0193	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—celiac disease	0.0145	0.0188	CbGeAlD
Bortezomib—PSMD2—blood—celiac disease	0.0142	0.0184	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—celiac disease	0.0141	0.0183	CbGeAlD
Bortezomib—PSMB8—blood—celiac disease	0.0141	0.0183	CbGeAlD
Bortezomib—PSMB1—pancreas—celiac disease	0.0134	0.0174	CbGeAlD
Bortezomib—PSMB2—pancreas—celiac disease	0.013	0.0169	CbGeAlD
Bortezomib—PSMD1—liver—celiac disease	0.0125	0.0162	CbGeAlD
Bortezomib—PSMB5—blood—celiac disease	0.0125	0.0162	CbGeAlD
Bortezomib—CYP3A4—urine—celiac disease	0.012	0.0156	CbGeAlD
Bortezomib—CYP2D6—urine—celiac disease	0.0118	0.0153	CbGeAlD
Bortezomib—PSMB1—lymphoid tissue—celiac disease	0.0116	0.015	CbGeAlD
Bortezomib—PSMB1—digestive system—celiac disease	0.0114	0.0148	CbGeAlD
Bortezomib—PSMB2—lymphoid tissue—celiac disease	0.0113	0.0146	CbGeAlD
Bortezomib—PSMB2—digestive system—celiac disease	0.0111	0.0145	CbGeAlD
Bortezomib—PSMD2—liver—celiac disease	0.0111	0.0144	CbGeAlD
Bortezomib—PSMB8—liver—celiac disease	0.011	0.0143	CbGeAlD
Bortezomib—PSMB1—blood—celiac disease	0.0109	0.0141	CbGeAlD
Bortezomib—PSMB2—blood—celiac disease	0.0106	0.0138	CbGeAlD
Bortezomib—PSMB5—liver—celiac disease	0.00974	0.0126	CbGeAlD
Bortezomib—SLC31A1—digestive system—celiac disease	0.00965	0.0125	CbGeAlD
Bortezomib—SLC31A1—blood—celiac disease	0.0092	0.0119	CbGeAlD
Bortezomib—PSMB1—liver—celiac disease	0.00851	0.011	CbGeAlD
Bortezomib—PSMB2—liver—celiac disease	0.0083	0.0108	CbGeAlD
Bortezomib—SLC31A1—liver—celiac disease	0.00719	0.00933	CbGeAlD
Bortezomib—CYP1A1—epithelium—celiac disease	0.00431	0.00559	CbGeAlD
Bortezomib—CYP2C19—digestive system—celiac disease	0.00407	0.00528	CbGeAlD
Bortezomib—PTGS1—connective tissue—celiac disease	0.00399	0.00517	CbGeAlD
Bortezomib—CYP2C19—blood—celiac disease	0.00388	0.00503	CbGeAlD
Bortezomib—PTGS1—epithelium—celiac disease	0.00379	0.00491	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—celiac disease	0.00365	0.00473	CbGeAlD
Bortezomib—CYP2C8—blood—celiac disease	0.00338	0.00439	CbGeAlD
Bortezomib—CYP1A2—digestive system—celiac disease	0.00332	0.00431	CbGeAlD
Bortezomib—CYP1A1—digestive system—celiac disease	0.00328	0.00425	CbGeAlD
Bortezomib—CYP1A2—blood—celiac disease	0.00317	0.00411	CbGeAlD
Bortezomib—CYP2C9—digestive system—celiac disease	0.00315	0.00409	CbGeAlD
Bortezomib—CYP1A1—blood—celiac disease	0.00312	0.00405	CbGeAlD
Bortezomib—CYP2C19—liver—celiac disease	0.00303	0.00393	CbGeAlD
Bortezomib—CYP2C9—blood—celiac disease	0.00301	0.0039	CbGeAlD
Bortezomib—PTGS1—digestive system—celiac disease	0.00288	0.00374	CbGeAlD
Bortezomib—PTGS1—blood—celiac disease	0.00274	0.00356	CbGeAlD
Bortezomib—CYP2C8—liver—celiac disease	0.00265	0.00343	CbGeAlD
Bortezomib—CYP1A2—liver—celiac disease	0.00248	0.00321	CbGeAlD
Bortezomib—CYP1A1—liver—celiac disease	0.00244	0.00317	CbGeAlD
Bortezomib—CYP3A4—digestive system—celiac disease	0.00241	0.00312	CbGeAlD
Bortezomib—CYP2D6—digestive system—celiac disease	0.00237	0.00307	CbGeAlD
Bortezomib—CYP2C9—liver—celiac disease	0.00235	0.00305	CbGeAlD
Bortezomib—CYP3A4—blood—celiac disease	0.00229	0.00297	CbGeAlD
Bortezomib—CYP2D6—blood—celiac disease	0.00226	0.00293	CbGeAlD
Bortezomib—CYP3A4—liver—celiac disease	0.00179	0.00233	CbGeAlD
Bortezomib—CYP2D6—liver—celiac disease	0.00176	0.00229	CbGeAlD
Bortezomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—CD80—celiac disease	0.00078	0.0034	CbGpPWpGaD
Bortezomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—CD80—celiac disease	0.00078	0.0034	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQA1—celiac disease	0.000774	0.00337	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—CD80—celiac disease	0.000769	0.00335	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MYO9B—celiac disease	0.000753	0.00328	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MYO9B—celiac disease	0.00075	0.00327	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MYO9B—celiac disease	0.000746	0.00325	CbGpPWpGaD
Bortezomib—PSMB2—Host Interactions of HIV factors—CD4—celiac disease	0.000746	0.00325	CbGpPWpGaD
Bortezomib—PSMB1—Host Interactions of HIV factors—CD4—celiac disease	0.000746	0.00325	CbGpPWpGaD
Bortezomib—PSMB5—Host Interactions of HIV factors—CD4—celiac disease	0.000746	0.00325	CbGpPWpGaD
Bortezomib—PSMB8—Host Interactions of HIV factors—CD4—celiac disease	0.000736	0.00321	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-DQB1—celiac disease	0.000724	0.00316	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TNFRSF14—celiac disease	0.000712	0.0031	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TNFRSF14—celiac disease	0.000712	0.0031	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TNFRSF14—celiac disease	0.000712	0.0031	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TNFRSF14—celiac disease	0.000702	0.00306	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—CD80—celiac disease	0.000689	0.003	CbGpPWpGaD
Bortezomib—PSMB2—B Cell Activation—CD80—celiac disease	0.000689	0.003	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—CD80—celiac disease	0.000689	0.003	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—CD80—celiac disease	0.000679	0.00296	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-DPB1—celiac disease	0.000668	0.00291	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-DPB1—celiac disease	0.000665	0.0029	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-DPB1—celiac disease	0.000662	0.00289	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TAGAP—celiac disease	0.000653	0.00285	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TAGAP—celiac disease	0.00065	0.00283	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TAGAP—celiac disease	0.000647	0.00282	CbGpPWpGaD
Bortezomib—PSMA1—HIV Infection—CD4—celiac disease	0.00064	0.00279	CbGpPWpGaD
Bortezomib—PSMD1—HIV Infection—CD4—celiac disease	0.000637	0.00278	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CTLA4—celiac disease	0.000634	0.00276	CbGpPWpGaD
Bortezomib—PSMD2—HIV Infection—CD4—celiac disease	0.000634	0.00276	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CTLA4—celiac disease	0.000631	0.00275	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CTLA4—celiac disease	0.000628	0.00274	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD79A—celiac disease	0.000605	0.00264	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD79A—celiac disease	0.000602	0.00262	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD79A—celiac disease	0.000599	0.00261	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MYO9B—celiac disease	0.000571	0.00249	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MYO9B—celiac disease	0.000571	0.00249	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MYO9B—celiac disease	0.000571	0.00249	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MYO9B—celiac disease	0.000563	0.00245	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-DQA1—celiac disease	0.000558	0.00243	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-DQA1—celiac disease	0.000555	0.00242	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-DQA1—celiac disease	0.000553	0.00241	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-DRB1—celiac disease	0.000551	0.0024	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—MBL2—celiac disease	0.000535	0.00233	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—MBL2—celiac disease	0.000532	0.00232	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—MBL2—celiac disease	0.00053	0.00231	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-DQB1—celiac disease	0.000522	0.00228	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-DQB1—celiac disease	0.000519	0.00226	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-DQB1—celiac disease	0.000517	0.00225	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-DPB1—celiac disease	0.000507	0.00221	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-DPB1—celiac disease	0.000507	0.00221	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-DPB1—celiac disease	0.000507	0.00221	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-DPB1—celiac disease	0.000499	0.00218	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TAGAP—celiac disease	0.000495	0.00216	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TAGAP—celiac disease	0.000495	0.00216	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TAGAP—celiac disease	0.000495	0.00216	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TAGAP—celiac disease	0.000488	0.00213	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD8A—celiac disease	0.000487	0.00212	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—RGS1—celiac disease	0.000485	0.00212	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD8A—celiac disease	0.000485	0.00211	CbGpPWpGaD
Bortezomib—PSMB2—HIV Infection—CD4—celiac disease	0.000485	0.00211	CbGpPWpGaD
Bortezomib—PSMB1—HIV Infection—CD4—celiac disease	0.000485	0.00211	CbGpPWpGaD
Bortezomib—PSMB5—HIV Infection—CD4—celiac disease	0.000485	0.00211	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—FCGR2A—celiac disease	0.000484	0.00211	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—RGS1—celiac disease	0.000483	0.00211	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD8A—celiac disease	0.000483	0.0021	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—FCGR2A—celiac disease	0.000482	0.0021	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—RGS1—celiac disease	0.000481	0.0021	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CTLA4—celiac disease	0.00048	0.00209	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CTLA4—celiac disease	0.00048	0.00209	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CTLA4—celiac disease	0.00048	0.00209	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—FCGR2A—celiac disease	0.000479	0.00209	CbGpPWpGaD
Bortezomib—PSMB8—HIV Infection—CD4—celiac disease	0.000478	0.00208	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—TNFAIP3—celiac disease	0.000475	0.00207	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CTLA4—celiac disease	0.000473	0.00206	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—TNFAIP3—celiac disease	0.000473	0.00206	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—TNFAIP3—celiac disease	0.00047	0.00205	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—PTPN2—celiac disease	0.000464	0.00202	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—PTPN2—celiac disease	0.000462	0.00201	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—PTPN2—celiac disease	0.000459	0.002	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD79A—celiac disease	0.000458	0.002	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD79A—celiac disease	0.000458	0.002	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD79A—celiac disease	0.000458	0.002	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD79A—celiac disease	0.000452	0.00197	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—LCT—celiac disease	0.000447	0.00195	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-DQA1—celiac disease	0.000423	0.00184	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-DQA1—celiac disease	0.000423	0.00184	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-DQA1—celiac disease	0.000423	0.00184	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-DQA1—celiac disease	0.000417	0.00182	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-DPB1—celiac disease	0.000405	0.00177	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—MBL2—celiac disease	0.000405	0.00177	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—MBL2—celiac disease	0.000405	0.00177	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—MBL2—celiac disease	0.000405	0.00177	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-DPB1—celiac disease	0.000404	0.00176	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-DPB1—celiac disease	0.000402	0.00175	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—MBL2—celiac disease	0.0004	0.00174	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-DRB1—celiac disease	0.000397	0.00173	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-DQB1—celiac disease	0.000395	0.00172	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-DQB1—celiac disease	0.000395	0.00172	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-DQB1—celiac disease	0.000395	0.00172	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-DRB1—celiac disease	0.000395	0.00172	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-DRB1—celiac disease	0.000393	0.00171	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-DQB1—celiac disease	0.00039	0.0017	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CTLA4—celiac disease	0.000384	0.00168	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CTLA4—celiac disease	0.000383	0.00167	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CTLA4—celiac disease	0.000381	0.00166	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCR4—celiac disease	0.000375	0.00164	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCR4—celiac disease	0.000373	0.00163	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCR4—celiac disease	0.000372	0.00162	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD8A—celiac disease	0.000369	0.00161	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD8A—celiac disease	0.000369	0.00161	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD8A—celiac disease	0.000369	0.00161	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RGS1—celiac disease	0.000368	0.0016	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RGS1—celiac disease	0.000368	0.0016	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RGS1—celiac disease	0.000368	0.0016	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD79A—celiac disease	0.000367	0.0016	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—FCGR2A—celiac disease	0.000367	0.0016	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—FCGR2A—celiac disease	0.000367	0.0016	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—FCGR2A—celiac disease	0.000367	0.0016	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD80—celiac disease	0.000367	0.0016	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD79A—celiac disease	0.000365	0.00159	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD80—celiac disease	0.000365	0.00159	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD8A—celiac disease	0.000364	0.00159	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD79A—celiac disease	0.000363	0.00158	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD80—celiac disease	0.000363	0.00158	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RGS1—celiac disease	0.000363	0.00158	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—FCGR2A—celiac disease	0.000362	0.00158	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TNFAIP3—celiac disease	0.00036	0.00157	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TNFAIP3—celiac disease	0.00036	0.00157	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TNFAIP3—celiac disease	0.00036	0.00157	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TNFAIP3—celiac disease	0.000355	0.00155	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—PTPN2—celiac disease	0.000352	0.00153	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—PTPN2—celiac disease	0.000352	0.00153	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—PTPN2—celiac disease	0.000352	0.00153	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—PTPN2—celiac disease	0.000347	0.00151	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-DQA1—celiac disease	0.000338	0.00148	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-DQA1—celiac disease	0.000337	0.00147	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-DQA1—celiac disease	0.000335	0.00146	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCR3—celiac disease	0.000319	0.00139	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCR3—celiac disease	0.000317	0.00138	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-DQB1—celiac disease	0.000317	0.00138	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCR3—celiac disease	0.000316	0.00138	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-DQB1—celiac disease	0.000315	0.00137	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—LCT—celiac disease	0.000315	0.00137	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-DQB1—celiac disease	0.000314	0.00137	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SH2B3—celiac disease	0.000311	0.00136	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SH2B3—celiac disease	0.000309	0.00135	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SH2B3—celiac disease	0.000308	0.00134	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-DPB1—celiac disease	0.000307	0.00134	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-DPB1—celiac disease	0.000307	0.00134	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-DPB1—celiac disease	0.000307	0.00134	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-DPB1—celiac disease	0.000303	0.00132	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-DRB1—celiac disease	0.000301	0.00131	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-DRB1—celiac disease	0.000301	0.00131	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-DRB1—celiac disease	0.000301	0.00131	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-DRB1—celiac disease	0.000296	0.00129	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD8A—celiac disease	0.000296	0.00129	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD8A—celiac disease	0.000294	0.00128	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD8A—celiac disease	0.000293	0.00128	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTLA4—celiac disease	0.000291	0.00127	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTLA4—celiac disease	0.000291	0.00127	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTLA4—celiac disease	0.000291	0.00127	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—LCT—celiac disease	0.000288	0.00126	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTLA4—celiac disease	0.000287	0.00125	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCR4—celiac disease	0.000284	0.00124	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCR4—celiac disease	0.000284	0.00124	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCR4—celiac disease	0.000284	0.00124	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCR4—celiac disease	0.00028	0.00122	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD4—celiac disease	0.00028	0.00122	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD4—celiac disease	0.000279	0.00121	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD79A—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD79A—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD79A—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD80—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD80—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD80—celiac disease	0.000278	0.00121	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD4—celiac disease	0.000277	0.00121	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD79A—celiac disease	0.000274	0.00119	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD80—celiac disease	0.000274	0.00119	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LCT—celiac disease	0.000257	0.00112	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-DQA1—celiac disease	0.000256	0.00112	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-DQA1—celiac disease	0.000256	0.00112	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-DQA1—celiac disease	0.000256	0.00112	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-DQA1—celiac disease	0.000253	0.0011	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCR3—celiac disease	0.000242	0.00105	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCR3—celiac disease	0.000242	0.00105	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCR3—celiac disease	0.000242	0.00105	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-DRB1—celiac disease	0.000241	0.00105	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-DQB1—celiac disease	0.00024	0.00105	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-DQB1—celiac disease	0.00024	0.00105	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-DQB1—celiac disease	0.00024	0.00105	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-DRB1—celiac disease	0.00024	0.00104	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-DRB1—celiac disease	0.000238	0.00104	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCR3—celiac disease	0.000238	0.00104	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LCT—celiac disease	0.000237	0.00103	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-DQB1—celiac disease	0.000237	0.00103	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SH2B3—celiac disease	0.000236	0.00103	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SH2B3—celiac disease	0.000236	0.00103	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SH2B3—celiac disease	0.000236	0.00103	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LCT—celiac disease	0.000235	0.00102	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SH2B3—celiac disease	0.000232	0.00101	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD8A—celiac disease	0.000224	0.000977	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD8A—celiac disease	0.000224	0.000977	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD8A—celiac disease	0.000224	0.000977	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD80—celiac disease	0.000222	0.000969	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD80—celiac disease	0.000221	0.000965	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD8A—celiac disease	0.000221	0.000963	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD80—celiac disease	0.00022	0.00096	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD4—celiac disease	0.000212	0.000925	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD4—celiac disease	0.000212	0.000925	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD4—celiac disease	0.000212	0.000925	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD4—celiac disease	0.000209	0.000912	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CD80—celiac disease	0.000205	0.000895	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CD80—celiac disease	0.000204	0.000891	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CD80—celiac disease	0.000203	0.000887	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LCT—celiac disease	0.000201	0.000874	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-DRB1—celiac disease	0.000182	0.000795	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-DRB1—celiac disease	0.000182	0.000795	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-DRB1—celiac disease	0.000182	0.000795	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-DRB1—celiac disease	0.00018	0.000784	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD4—celiac disease	0.00017	0.00074	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD4—celiac disease	0.000169	0.000737	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD80—celiac disease	0.000169	0.000735	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD80—celiac disease	0.000169	0.000735	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD80—celiac disease	0.000169	0.000735	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD4—celiac disease	0.000168	0.000733	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD80—celiac disease	0.000166	0.000724	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CD4—celiac disease	0.000157	0.000683	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CD4—celiac disease	0.000156	0.00068	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD80—celiac disease	0.000156	0.000678	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD80—celiac disease	0.000156	0.000678	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD80—celiac disease	0.000156	0.000678	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CD4—celiac disease	0.000155	0.000677	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LCT—celiac disease	0.000155	0.000675	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD80—celiac disease	0.000153	0.000669	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CD80—celiac disease	0.000144	0.000627	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CD80—celiac disease	0.000143	0.000624	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CD80—celiac disease	0.000142	0.000621	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD4—celiac disease	0.000129	0.000561	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD4—celiac disease	0.000129	0.000561	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD4—celiac disease	0.000129	0.000561	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD4—celiac disease	0.000127	0.000553	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD4—celiac disease	0.000119	0.000518	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD4—celiac disease	0.000119	0.000518	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD4—celiac disease	0.000119	0.000518	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD4—celiac disease	0.000117	0.000511	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CD80—celiac disease	0.000109	0.000475	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CD80—celiac disease	0.000109	0.000475	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CD80—celiac disease	0.000109	0.000475	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CD80—celiac disease	0.000107	0.000468	CbGpPWpGaD
